These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 35078435)

  • 41. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
    Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
    Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of circadian clock gene expression is associated with tumor progression in breast cancer.
    Cadenas C; van de Sandt L; Edlund K; Lohr M; Hellwig B; Marchan R; Schmidt M; Rahnenführer J; Oster H; Hengstler JG
    Cell Cycle; 2014; 13(20):3282-91. PubMed ID: 25485508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
    Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
    Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. KAT2B is an immune infiltration-associated biomarker predicting prognosis and response to immunotherapy in non-small cell lung cancer.
    Zhou X; Wang N; Zhang Y; Yu H; Wu Q
    Invest New Drugs; 2022 Feb; 40(1):43-57. PubMed ID: 34499335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer.
    Zhong KZ; Chen WW; Hu XY; Jiang AL; Zhao J
    Int J Clin Exp Pathol; 2014; 7(7):4545-51. PubMed ID: 25120851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TAZ is an independent prognostic factor in non-small cell lung carcinoma: Elucidation at protein level.
    Malik SA; Khan MS; Dar M; Hussain MU; Mudassar S
    Cancer Biomark; 2017; 18(4):389-395. PubMed ID: 28128737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advances in the Study of Circadian Genes in Non-Small Cell Lung Cancer.
    Zhang H; Liu R; Zhang B; Huo H; Song Z
    Integr Cancer Ther; 2022; 21():15347354221096080. PubMed ID: 35575281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A prognostic model of non small cell lung cancer based on TCGA and ImmPort databases.
    Yang D; Ma X; Song P
    Sci Rep; 2022 Jan; 12(1):437. PubMed ID: 35013450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 50. Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer.
    Chen Y; Chen G; Li J; Huang YY; Li Y; Lin J; Chen LZ; Lu JP; Wang YQ; Wang CX; Pan LK; Xia XF; Yi X; Chen CB; Zheng XW; Guo ZQ; Pan JJ
    JAMA Netw Open; 2019 Sep; 2(9):e1911895. PubMed ID: 31539077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer.
    Liu YZ; Yang H; Cao J; Jiang YY; Hao JJ; Xu X; Cai Y; Wang MR
    Sci Rep; 2016 Apr; 6():24786. PubMed ID: 27098511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.
    Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y
    Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
    Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
    Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic significance of epigenetic regulatory gene expression in patients with non-small-cell lung cancer.
    Tu Z; Chen X; Tian T; Chen G; Huang M
    Aging (Albany NY); 2021 Feb; 13(5):7397-7415. PubMed ID: 33658396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer.
    Nagy Á; Pongor LS; Szabó A; Santarpia M; Győrffy B
    Int J Cancer; 2017 Feb; 140(4):930-937. PubMed ID: 27859136
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene expression and prognosis of x-ray repair cross-complementing family members in non-small cell lung cancer.
    Fan Y; Gao Z; Li X; Wei S; Yuan K
    Bioengineered; 2021 Dec; 12(1):6210-6228. PubMed ID: 34486486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of ERBB4 mutations in the prognosis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors.
    Hu X; Xu H; Xue Q; Wen R; Jiao W; Tian K
    Mol Med; 2021 Oct; 27(1):126. PubMed ID: 34620079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systematic analysis of circadian genes in a population-based sample reveals association of TIMELESS with depression and sleep disturbance.
    Utge SJ; Soronen P; Loukola A; Kronholm E; Ollila HM; Pirkola S; Porkka-Heiskanen T; Partonen T; Paunio T
    PLoS One; 2010 Feb; 5(2):e9259. PubMed ID: 20174623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.